• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amsterdam Molecular Therapeutics Holding

+ Add to Watchlist


Price not available for RHP:GR

Snapshot for Amsterdam Molecular Therapeutics Holding (RHP)

Open: - Day's Range: - Volume: 0
Previous Close: 0.003 52wk Range: - 1-Yr Rtn: -

Stock Chart for RHP

No chart data available.
  • RHP:GR
  • 1M
  • 1Y
Interactive RHP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHP

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2012) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHP

No data available

Company Profile & Key Executives for RHP

Amsterdam Molecular Therapeutics Holding is a biotechnology company. The Company researches treatments for metabolic disorders, ocular diseases, and central and peripheral nervous system conditions.

Carlos R CamozziChief Medical OfficerJanneke De WalMember-Mgmt Board
Arnold VroegeMember-Mgmt BoardRob JanssenDir:Comm & Investor Relations
More Company Profile & Key Executives for RHP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil